Philip Sloan

Professor Sloan is a practicing pathologist specialising in head & neck, skin and bone & soft tissue pathology. Philip currently engages in research into advanced cellular therapies and novel diagnostic tests. He was director of the CEPA Biobank and co-director of the EPSRC/MRC Molecular Pathology Node, that merged in 2021 to form NovoPath. He has a particular interest and expertise in Quality Assurance for laboratory medicine and clinical trials.

Philip graduated from Newcastle University in 1974, gained his PhD from the University of Bristol in 1978. He was Professor of Experimental Pathology at the University of Manchester and R&D Director of CMHT until 2007. He has authored or co-authored over 300 peer reviewed publications and five books. Currently he a member of the WHO collaborating group for OMPDs and cancer, and is a lead author for ICCR guidelines. Philip is particularly enthusiastic about working with industry partners as well as academic researchers, for patient benefit.